As infecções respiratórias agudas são uma importante causa de morbidade e mortalidade infantil em todo o mundo. Algumas dessas infecções podem resultar em Síndrome Respiratória Aguda Grave (SRAG). Os vírus respiratórios são os principais responsáveis por esta doença. O monitoramento e a vigilância das SRAG e dos vírus respiratórios são importantes para a gestão em saúde minimizando o impacto destas infecções respiratórias. O presente estudo buscou analisar a sazonalidade e impacto clínico das infecções causadas por vírus respiratórios em crianças internadas em hospital pediátrico do Paraná. Foram incluídos no estudo 229 pacientes de 0 até 15 anos de idade, de janeiro de 2012 a dezembro de 2015, com diagnóstico clínico de SRAG e amostra respiratória coletada e enviada ao Laboratório Central do Estado do Paraná para diagnóstico do agente etiológico. A busca dos casos de SRAG foi realizada utilizando o prontuário eletrônico GSUS (Gestão da Assistência de Saúde do SUS), arquivos do setor de fisioterapia e informações do Núcleo de Controle de Infecções hospitalares do hospital do estudo. Dos pacientes incluídos na pesquisa, foi preenchido um formulário de coleta de dados e posteriormente estes foram analisados de acordo com os objetivos da pesquisa. As análises estatísticas foram efetuadas com o pacote estatístico GRAPHPAD PRISM e foi considerado um nível de significância de 5%. A maioria dos pacientes da amostra pertencia à faixa etária de 0 a 6 meses de idade, não houve sexo predominante. No presente estudo as amostras positivas para pelo menos um agente etiológico contabilizaram 76,41%, e o vírus mais prevalente foi o Vírus Sincicial respiratório (VSR). Quanto à sazonalidade da detecção viral, houve predominância no final de outono e início do inverno, mais acentuada para o VSR. Quando analisada as três temperaturas ambientais da região, a incidência de SRAG foi significativamente maior no quartil descendente da temperatura média para mínima. Não foi observada diferença significativa entre os grupos etiológicos pesquisados com relação ao tempo desde o início dos sintomas até a internação. Houve predominância de internamentos em Unidade de Terapia Intensiva. O tempo de internamento foi significativamente maior naqueles pacientes com doença de base e não alterou conforme os agentes etiológicos identificados ou presença de codetecção. Os pacientes que apresentaram padrão misto na radiografia de tórax tiveram um tempo de internamento significativamente maior do que aqueles que apresentaram o padrão infiltrado intersticial. O tempo total foi significativamente menor no grupo Metapneumovírus em relação aos grupos Bordetella pertussis, Influenza, Rinovírus e grupo dos pacientes sem agentes infecciosos detectados. O tempo de ventilação mecânica não apresentou diferenças significativas entre os grupos etiológicos nem com relação à presença ou não de codetecção. A maior parte dos pacientes recebeu alta hospitalar, mas ocorreram três óbitos devido a SRAG, todos em pacientes com alguma doença de base ou condições de risco. / Acute respiratory infections are the most important cause of children morbidity and mortality worldwide. Some of these infections can result in Severe Acute Respiratory Syndrome (SARS). Respiratory viruses are primarily responsible for SARS. The monitoring and surveillance of SARS and respiratory viruses are important for health management, minimizing the impact of these respiratory infections. The present study was about the seasonality and clinical impact of respiratory viruses in children admitted to a pediatric reference hospital. The study included 229 children from 0 to 15 years old, from January 2012 to December 2015, with clinical diagnosis of SARS and respiratory sample collected and sent to the Central Laboratory of the State of Paraná for etiological agent analysis. The search for SARS cases was performed using the GSUS (Health Care Management of SUS) electronic filesystem, records of the center of physiotherapy and information of the Hospital Infection Control Center of the studied hospital. Of the patients included in the research, data collection forms were filled out and later analyzed according to the research objectives. Statistical analyzis were performed with the statistical package GRAPHPAD PRISM and a significance level of 5% was considered. The majority of patients in the sample belonged to the age group 0-6 months of age, and there was no predominant sex. Regarding the risk factors for viral infection, the presence of comorbidity or underlying disease was the most prevalent factor. In the present study, the positive samples for at least one etiological agent accounted for 76.41%, and the most prevalent virus was Respiratory Syncytial Virus (RSV). As for the seasonality of viral detection, there was a predominance in the late fall and early winter, which was more pronounced for RSV. When the environmental temperatures of the region were analyzed, the incidence of SARS was significantly higher in the descending quartile of the average minimum temperature. No significant difference was observed between the studied etiological groups in relation to the time from the beginning of the symptoms until the hospitalization. There was a predominance of hospitalizations in the Intensive Care Unit. The hospitalization time was significantly higher in patients with underlying disease or comorbidities and did not change according to the identified etiological agents or the presence of codetection. Patients who presented a mixed pattern on chest radiography had a significantly longer hospitalization time than those who had the interstitial infiltrate pattern. The total time was significantly lower in the Metapneumovirus group than in the Bordetella pertussis, Influenza, Rhinovirus and group of patients without detected infectious agents. Most patients were discharged from hospital, but there were three deaths due to SARS, all in patients with some underlying disease or risk conditions.

O HBoV é um novo parvovírus que foi isolado pela primeira vez em 2005 nas secreções respiratórias de pacientes humanos que tiveram pneumonia. Desde então, é associado a doenças do trato respiratório superior e doença gastrointestinal em pacientes adultos e pediátricos, desde a sua descoberta na Suécia e posteriormente em diversos países no Mundo. Quase todos os estudos foram realizados em amostras de secreção do trato respiratório, normalmente, de crianças com menos de 2 anos de idade e a maioria com infecção respiratória. As taxas de prevalência variam de 1,5% a 19% nos diferentes países. A Análise filogenética deste novo vírus demonstrou que tratava-se de um parvovirus, mais estreitamente relacionado ao parvovírus bovino e ao minuto vírus canino e por isso foi denominado de Bocavírus Humano. A variabilidade genética do HBoV é baixa e estudos filogenéticos indicam que duas linhagens circulam paralelamente ao redor do mundo. Entretanto, como ainda é um vírus relativamente novo, devem se feitos estudos mais detalhados de suas variantes. Em nosso estudo, com a finalidade de determinar a prevalência e conhecer a variabilidade genética do HBoV circulante, foram analisados de janeiro de 2008 a fevereiro de 2010, 935 amostras de aspirado de nasofaringe de crianças com menos de 2 anos de idade, com doença respiratória aguda, internadas no Hospital da Santa Casa de Misericórdia de São Paulo. Pela técnica de PCR, obtivemos 47 (4,7%) amostras positivas para HBoV e dessas 27 amostras apresentaram coinfecção com outros vírus respiratórios, 45 amostras foram seqüenciadas na região da VP1/VP2 de um fragmento de 658 nt. A análise filogenética, quando comparada com seqüência do genBank representativas de vários países, mostrou a circulação, em nossa amostragem, de grupos de HBoV semelhantes aos que circulam no Japão e Taiwan. A variabilidade genética entre as nossas amostras foram inferiores a 1%, tanto entre si como quando comparadas com as amostras do genBank. / HBoV is a new parvovirus which was first isolated in 2005 from respiratory secretions from human patients who had pneumonia. It has been associated with respiratory and gastrointestinal diseases in adult and pediatric patients since its discovery in Sweden and later in several countries worldwide. Almost all studies were performed on samples of secretions from the respiratory tract, usually in children under 2 years of age. Prevalence rates vary from 1.5% to 19% in different countries. The phylogenetic analysis of this new virus showed that it was a parvovirus, more closely related to bovine parvovirus and canine minute virus, and therefore called Human Bocavirus. The genetic variability of HBoV is low and phylogenetic studies indicate that there are two strains circulating alongside around the world. However, as it is still a relatively new virus, more detailed studies of its variants should be carried out. In our study, 935 samples of nasopharyngeal aspirate from children under 2 years old with acute respiratory disease, patients at Santa Casa de Misericordia Hospital, São Paulo, were analyzed from February 2008 to February 2010 in order to determine the prevalence and genetic variability of HBoV stock. Using the PCR method, we obtained 47 (4.7%) positive samples for HBoV from which 27 showed coinfection with other respiratory viruses; 45 samples from a fragment of 658 nt were sequenced in the VP1/VP2 region. The phylogenetic analysis, when compared with GenBank sequences representing several countries, showed the presence in our samples of groups of HBoV similar to those circulating in Japan and Taiwan. Genetic variation in our samples were below 1%, both among themselves and when compared with samples from GenBank.

O Vírus Respiratório Sincicial Humano (HRSV) é considerado o principal causador de doenças agudas do trato respiratório inferior durante a infância, sendo o principal responsável por um elevado índice de hospitalização de crianças com até cinco anos de idade. Possui distribuição mundial, podendo acometer todas as faixas etárias, entretanto as crianças de 6 semanas a 9 meses são as que desenvolvem problemas mais sérios, como pneumonia e bronquiolite. A epidemia de HRSV apresenta uma sazonalidade bem clara, ocorrendo anualmente no período de outono tardio, inverno ou início da primavera, mas não durante o verão. No presente estudo foi realizada a análise da região G2 da glicoproteína G do HRSV. Um total de 44 amostras positivas para o HRSV do Hospital Universitário (HU) da Universidade de São Paulo (USP), nos anos de 2007-2008, foram seqüenciadas e posteriormente analisadas, sendo então comparadas com seqüências obtidas do NCBI/GeneBank. A análise filogenética mostrou que os genótipos GA2 e GA5, do grupo A, foram os predominantes nos anos de 2007 e 2008, alternando o padrão verificado nos anos anteriores, onde os genótipos do grupo B foram altamente predominantes. A comparação das mutações sinônimas e não sinônimas mostrou uma grande evidência de seleção positiva nos genótipos GA2 e GA5 do grupo A. / Human Respiratory Syncytial Virus (HRSV) is considered the most common cause of lower respiratory tract disease in infants and young children and are the main guilty for the elevated children hospitalizations rate under 5 years of age. The HRSV has a world-wide distribution, being able to attack all the ages however the 6 weeks to 9 months children of are the ones that develop more serious problems as pneumonia and bronquiolite. The HRSV outbreak presents a well defined season, occurring annually in the delayed falls period, winter or springs beginning, but not during the summer. In the present study, we performed a phylogenetic analysis from G2 region of HRSV G glycoprotein. Forty four samples positive for HRSV from University Hospital (UH) of University of Sao Paulo (USP) in 2007-2008, were submitted to sequencing by PCR and compared with GenBank sequences. Phylogenetic analysis revealed that HRSV group A genotypes GA2 and GA5 was the predominant in 2007-2008, alternating the standard verified in the previous years, where the group B genotypes had been highly predominant. Comparison of the synonymous/nonsynonymous mutation ratios showed greater evidence for positive selection pressure for group A genotypes GA2 and GA5.

M. Tech. (Department of Biotechnology, Faculty of Applied and Computer Sciences), Vaal University of Technology. / Background: There are critical unmet needs for improved strategies in the detection and diagnosis of M.tuberculosis infection in children, and for prevention of tuberculosis disease in children. Bacillus Calmette-Guérin (BCG) vaccination has limited the utility of tuberculin skin testing (TST) in areas with high vaccine coverage. Objectives: The aim of this study was to estimate the prevalence of M.tuberculosis infection in children with household tuberculosis contacts, using QFT-GIT testing in comparison with TST. Methods: This study was a cross-sectional design to assess the performance of a new T-cell based blood test, namely QuantiFERON-TB Gold In Tube (QFT-GIT), for diagnosis of tuberculosis infection in the children (n=182) of adults (n=124) with pulmonary tuberculosis, additionally to determine the prevalence of M.tuberculosis infection in children with household tuberculosis contacts, using QFT-GIT testing in comparison with TST. The study was carried out at Chris Hani Hospital. For children involved in the study, tuberculosis exposure information was obtained, together with TST, QFT-GIT, and HIV testing. Data obtained from both experiments was statistically analysed using SPSS version 24 to determine whether there was a significant agreement between QFT-GIT and TST on the detection of M.tuberculosis prevalence in children with house hold contacts with confirmed M.tuberculosis infection. Results: This study examined the sensitivity and specificity of the QFT-GIT tests compared with the standard TST for diagnosing latent tuberculosis disease in paediatric contacts. Because of the lack of a latent tuberculosis “gold standard”, the specificity and sensitivity of QFT-GIT was calculated with a two-by-two table method. The specificity of the QFT-GIT was 84% and the sensitivity was 85%. There was a good correlation between QFT-GIT and TST (Cohen’s kappa of 0.705). Seventeen percent (17%) of the 182 children tested by QFT-GIT yielded indeterminate results. Age was associated with indeterminate QFT-GIT results in paediatric tuberculosis contacts. Point prevalence for QFT-GIT was recorded as 31% at baseline and 39.5% after six months indicating variability between QFT-GIT results at baseline and after six months. Conclusion: It was concluded that the prevalence of tuberculosis infection was common among South African children who live with an adult with active tuberculosis. The agreement between QFT-GIT assay and TST for the diagnosis of latent tuberculosis in children was high. Although TST and QFT-GIT assays appeared comparable, QFT-GIT showed higher positivity rate amongst those contacts with reported household tuberculosis exposure compared to TST. The QFTGIT assay was a better indicator of the risk of M.tuberculosis infection than TST in a BCG-vaccinated population.

Title Best current evidence on chest physiotherapy in non-ventilated paediatric patients (0 to 24 months) with bronchiolitis: a systematic review. Purpose To determine the current scientific evidence for using three chest physiotherapy modalities namely percussion, postural drainage and suctioning in paediatric patients (0 to 24 months). Relevance The field of cardiopulmonary physiotherapy seems to be a neglected area in physiotherapy, with a subsequently limited evidence base. The author observed that in various clinical settings physiotherapists tend to administer routine chest physiotherapy to paediatric patients with bronchiolitis. Findings from this study may assist physiotherapists in their choice of effective treatment options. Sources The following databases were searched for evidence: African Health Line, CINAHL, Cochrane, Ebsco Host, Emerald Host, UP E-theses/dissertations, PEDro, Medline Ovid, Sabinet, Science Direct, Up To Date. Methodology This was a systematic review. The databases were reviewed by making use of a specified search strategy customised for each database. Keywords were: physiotherapy/physical therapy, bronchiolitis and paediatric/pediatric in combination with percussion, postural drainage and suction. The search yielded 10,016 study titles. Studies were chosen from the population of studies using pre-set inclusion and exclusion criteria. These criteria were applied to the titles, abstracts and full-text articles as appropriate. Five full text-articles were appraised and based on the scores from the appraisal three were included in the final sample. Data analysis Appraisal instruments from the National Health System Critical Appraisal Skills Programme (NHS CASP) and the PEDro scale (for randomised controlled trials) were used to evaluate and score the sample. Scoring was done independently by two researchers, and agreement reached through negotiation. The evidence was synthesised and graded according to the Sackett hierarchy of evidence. Results Owing to the heterogeneity of the sample, and the nature of results reported, a meta-analysis was not possible. Results from this study reveal that there is no evidence to support routine chest physiotherapy in uncomplicated viral bronchiolitis amongst the paediatric population. Chest physiotherapy does not decrease length of hospital stay, oxygen requirements or clinical scores indicating distress/morbidity. However, with secondary bacterial respiratory infections, chest physiotherapy may be indicated, depending on the assessment of each individual patient. Conclusion Percussion, postural drainage and suctioning are not effective in the management of bronchiolitis in children, newborn to 24 months old, except in individually assessed cases with secondary bacterial infection. In this subset, physiotherapy must be customised to the patient. Therefore routine physiotherapy is not indicated. Implications Chest physiotherapy should be based on a complete evaluation and on clinical merit, as well as on evidence and patient preference. Education of physiotherapy students at universities as well as doctors regarding the current evidence for chest physiotherapy in paediatric bronchiolitis is essential. Doctors and clinicians need to be made aware that routine chest physiotherapy for paediatric patients with bronchiolitis should not be prescribed. AFRIKAANS : Titel Die beste huidige bewyse aangaande longfistioterapie vir non geventileerde pediatriese pasiënte (0 tot 24 maande) met brongiolitis: 'n sistematiese oorsig. Doel Om huidige wetenskaplike bewyse vir die gebruik van drie long fisioterapietegnieke naamlik beklopping, posturale dreinasie en suiging in pediatriese pasiënte (0 tot 24 maande) te bepaal. Toepaslikheid Die veld van pediatriese fisioterapie blyk 'n verwaarloosde area van navorsing te wees, met gevolglik beperkte bewysbasis. Die navorser het ondervind dat fisioterapeute dikwels in kliniese praktyk roetine longfisioterapie in pediatriese pasiënte met brongiolitis toepas. Bewyslewering vanuit hierdie studie kan fisioterapeute help met die keuse van effektiewe behandelingsprosedures. Bronne Die volgende databasisse is deursoek vir bewyse: African Health Line, CINAHL, Cochrane, Ebsco Host, Emerald Host, UP e-theses and dissertations, PEDro, Medline, Sabinet, Science Direct en Up To Date. Die soektog het 10,016 titels gelewer. Metode 'n Sistematiese oorsig van die data is uitgevoer deur 'n gespesifiseerde soekstrategie, aangepas vir elke databasis, te volg. Sleutelwoorde was: “physiotherapy/physical therapy”, “bronchiolitis” and “paediatric/pediatric” in kombinasie met “percussion”, “postural drainage” and “suction”. Voorafbepaalde insluitings- en uitsluitingskriteria is toegepas op titels, abstrakte en artikels soos toepaslik. Data analise Evalueringsinstrumente van die “National Health System Critical Appraisal Skills programme” (NHS CASP) asook die PEDro skaal (ewekansige gekontroleerde eksperiment) is gebruik vir evaluasie van en puntetoedeling vir die verkose studies. Die puntetoekenning is onafhanklik deur twee navorsers gedoen en konsensus is bereik deur onderhandeling. Die inligting verkry is gesintetiseer en gegradeer aan die hand van die Sackett hiërargie van bewyse. As gevolg van die heterogeniteit van die ingeslote studies en die aard van die resultate was 'n meta-analise nie moontlik nie. Resultate Die studie het bevind dat daar geen bewyse is vir roetine borskasfisioterapie van ongekompliseerde akute virale pediatriese brongiolitis nie. Borskasfisioterapie verminder nie die duur van hospitaalverblyf, suurstofbehoeftes of die kliniese respiratoriese aanduiding van stres in die pasiënte nie. In die geval van sekondêre bakteriële respiratoriese infeksies mag borskasfisoterapie egter geindikeerd wees, afhangend van die evaluasie van elke individuele pasiënt. Gevolgtrekking Beklopping, posturale dreinasie, en suiging as roetine behandeling is nie effektief in die behandeling van brongiolitis in pasgebore tot 24 maand oue pasiënte nie, behalwe individuele gevalle met sekondêre bakteriële infeksies. In hierdie spesifieke subgroep moet borskasfisioterapie aangepas word vir pasiënt. Roetine fisioterapie is dus nie aangedui nie. Implikasies Borskasfisioterapie moet gebasseer wees op 'n volledige evaluasie en kliniese meriete, asook bewyslewering en die pasiënt se voorkeure. Opleiding van fisioterapie studente by universiteite, asook dokters aangaande die huidige bewyslewering vir borskasfisioterapie in pediatriese brongiolitis is belangrik. Dokters en klinici moet bewus gemaak word dat roetine borskasfisioterapie vir pediatriese brongiolitis pasiënte nie voorgeskryf moet word nie. Additional information available on a CD stored at the Merensky Library. / Dissertation (MPhysT)--University of Pretoria, 2011. / Physiotherapy / unrestricted

<p><strong>Background</strong>: Human rhinovirus/enterovirus (HRV/ENT) infections are commonly identified in children with acute respiratory infections (ARIs), but data on their clinical severity remains limited. We compared the clinical severity of HRV/ENT to respiratory syncytial virus (RSV), influenza A/B (FLU) and other common respiratory virus in children.</p> <p><strong>Methods</strong>: Retrospective study of children with ARIs and confirmed single positive viral infections on mid-turbinate swabs by molecular assays. Outcome measures included hospital admission and, for inpatients, a composite end-point consisting of intensive care admission, hospitalization greater than 5 days, oxygen requirements or death.</p> <p><strong>Results</strong>: A total of 116 HRV/ENT, 102 RSV, 99 FLU and 64 other common respiratory viruses were identified. Children with single HRV/ENT infections presented with significantly higher rates of underlying immunosuppressive conditions compared to those with RSV (37.9% vs 13.6%; p</p> <p><strong>Conclusions</strong>: Children with HRV/ENT had a more severe clinical course than those with RSV and FLUA/B infections and often had significant comorbidities. These findings emphasize the importance of considering HRV/ENT infection in children presenting with severe acute respiratory tract infections.</p> / Master of Science (MSc)